Optiray 350 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during X-ray and CT scans. Ideal for intra-arterial and intravenous administration, it supports clear imaging for accurate diagnosis.

Optiray 350 741 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during diagnostic imaging. It is commonly administered for X-ray and CT scans, helping healthcare professionals to better visualize blood vessels, organs, and tissues. This contrast agent is particularly useful in procedures requiring detailed imaging, such as angiography and computed tomography.

When administered, Optiray 350 741 mg/mL may cause a temporary warm sensation or flushing. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly. Severe reactions are rare but should be reported to a healthcare provider immediately.

Optiray 350 741 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity and effectiveness of the contrast agent.

Optiray 350 741 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to discuss all current medications with a healthcare provider before undergoing procedures involving this contrast agent. Alcohol and other substances that may affect kidney function should be avoided to minimize potential interactions.